Kevin Bullis

A View from Kevin Bullis

Averting a Nano Tragedy

A report released today calls for a systematic approach to risk research in nanotechnologies.

  • July 19, 2006

Although there is no proof of health risks to humans from nanoparticles, studies do show that materials at this scale behave in some worrying ways, for example, by slipping from the lungs into the bloodstream, and infiltrating other organs, possibly even the brain.

But current efforts at assessing the risk of nanoparticles, including ones already used in sunscreens, face creams, and food supplements, are unfocused and leave gaps in our understanding that “at best…create uncertainties – and at worst, dangers – for workers, companies, consumers, investors, and insurers,” according to Andrew Maynard, chief science advisor for the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars in Washington, DC.

Today, the center released a new report calling for a systematic approach to risk research into nanotechnologies that would include research in a number of areas: the toxicity of substances, how to handle them in the workplace, possible links to specific diseases, and the long-term ways to predict what nanomaterials are likely to be dangerous – and how to design them to improve their safety.

The report also calls for more funding: a total of $50 million per year for two years, with more to follow.

This could be a hard sell at a time when attention is focused on high fuel prices and the steep bills from the conflict in Iraq.

Might it take a serious problem, then, with people getting hurt, before nanotoxicity research gets the attention it needs?

“I sincerely hope not,” Maynard told me over the phone. “My hope is that people see the need and the urgency to invest in this. If it does take an incident to galvanize people, that will be very sad, indeed, because it means we will have lost the opportunity to do something preemptively.” – By Kevin Bullis

The latest Insider Conversation is live! Listen to the story behind the story.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly magazine delivery and unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look: exclusive early access to important stories, before they’re available to anyone else

    Insider Conversations: listen in on in-depth calls between our editors and today’s thought leaders

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.